Business Context and Reporting Period
This Form 8-K filing by Anthem, Inc. (now Elevance Health, Inc.) covers events occurring on November 14, 2017, and November 21, 2017. The report details a significant capital market transaction involving the issuance of new debt securities and the execution of tender offers for existing debt.
Key Financial Metrics and Transaction Details
New Debt Issuance: The Company closed the sale of $5.5 billion in aggregate principal amount of new notes (the "New Notes").
- 2020 Notes: $900 million at 2.500% interest.
- 2022 Notes: $750 million at 2.950% interest.
- 2024 Notes: $850 million at 3.350% interest.
- 2027 Notes: $1,600 million at 3.650% interest.
- 2047 Notes: $1,400 million at 4.375% interest.
Proceeds: The Company received net proceeds of approximately $5,457.8 million after deducting underwriting discounts and offering expenses.
Debt Repurchase (Tender Offer): The Company accepted for purchase $185,147,000 aggregate principal amount of its 7.000% Notes due 2019 (the "Any and All Notes").
Material Changes and Use of Proceeds
The primary material change is the restructuring of the Company's debt profile through the issuance of new notes at varying maturities and interest rates. The net proceeds from the new offering are designated for the following specific purposes:
- Funding previously announced acquisitions of HealthSun Health Plans, Inc. and America's 1st Choice of South Carolina, Inc.
- Funding the purchase price for the "Any and All Notes" and "Maximum Tender Offer Notes" (including accrued interest and early tender premiums).
- Redeeming any "Any and All Notes" not validly tendered.
- General corporate purposes, including working capital, repayment of other debt, and share repurchases.
Outlook, Risks, and Contingencies
Redemption Rights: The New Notes are redeemable at the Company's option prior to specific "Par Call Dates" at a price equal to the greater of 100% of principal or the present value of remaining payments plus a make-whole premium. On or after the Par Call Dates, they are redeemable at 100% of principal plus accrued interest.
Change of Control: If a change of control occurs and the notes are downgraded below investment grade by Moody's, S&P, and Fitch, the Company must offer to repurchase the notes at 101% of principal plus accrued interest.
Events of Default: Default triggers include failure to pay principal or interest, breach of indenture terms for 90 days, or bankruptcy proceedings.
Related Party Transactions: Certain underwriters (e.g., UBS Securities LLC) are acting as financial advisors for the HealthSun acquisition and may hold positions in the Company's outstanding notes, creating potential conflicts of interest regarding the tender offers.
Investor Verification Checklist
- Verify the final closing of the HealthSun Health Plans and America's 1st Choice acquisitions to confirm the allocation of proceeds.
- Confirm the total amount of "Maximum Tender Offer Notes" (5.950% due 2034, 5.850% due 2036, 6.375% due 2037, 5.800% due 2040, and 5.100% due 2044) accepted for purchase, as this filing only explicitly details the results for the 7.000% Notes due 2019.
- Review the "Computation of Ratio of Earnings to Fixed Charges" (Exhibit 12.1) to assess the impact of the new debt service obligations on leverage ratios.
- Monitor the Company's credit ratings to ensure they remain above investment grade to avoid triggering the mandatory repurchase provision.